A new trading day began on Monday, with Rein Therapeutics Inc (NASDAQ: RNTX) stock price up 11.82% from the previous day of trading, before settling in for the closing price of $1.57. RNTX’s price has ranged from $1.04 to $4.16 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 31.90%. Meanwhile, its annual earnings per share averaged 72.51%. With a float of $21.66 million, this company’s outstanding shares have now reached $23.05 million.
Rein Therapeutics Inc (RNTX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Rein Therapeutics Inc is 8.02%, while institutional ownership is 27.49%. The most recent insider transaction that took place on Oct 28 ’25, was worth 247,965. In this transaction 10% Owner of this company bought 178,392 shares at a rate of $1.39, taking the stock ownership to the 500,000 shares. Before that another transaction happened on Oct 27 ’25, when Company’s 10% Owner bought 97,482 for $1.37, making the entire transaction worth $133,544. This insider now owns 822,258 shares in total.
Rein Therapeutics Inc (RNTX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 72.51% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 34.86% during the next five years compared to 31.90% growth over the previous five years of trading.
Rein Therapeutics Inc (NASDAQ: RNTX) Trading Performance Indicators
Here are Rein Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.69, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.81 in one year’s time.
Technical Analysis of Rein Therapeutics Inc (RNTX)
Looking closely at Rein Therapeutics Inc (NASDAQ: RNTX), its last 5-days average volume was 9.38 million, which is a jump from its year-to-date volume of 0.3 million. As of the previous 9 days, the stock’s Stochastic %D was 60.86%.
During the past 100 days, Rein Therapeutics Inc’s (RNTX) raw stochastic average was set at 62.28%, which indicates a significant increase from 57.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1603 in the past 14 days, which was higher than the 0.1282 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2708, while its 200-day Moving Average is $1.6521. However, in the short run, Rein Therapeutics Inc’s stock first resistance to watch stands at $2.0967. Second resistance stands at $2.4433. The third major resistance level sits at $2.7067. If the price goes on to break the first support level at $1.4867, it is likely to go to the next support level at $1.2233. Now, if the price goes above the second support level, the third support stands at $0.8767.
Rein Therapeutics Inc (NASDAQ: RNTX) Key Stats
With a market capitalization of 41.21 million, the company has a total of 23,305K Shares Outstanding. Currently, annual sales are 0 K while annual income is -62,880 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,820 K.
